{"id":"W4375955180","doi":"10.1111/ejh.13982","title":"<scp>PD‐L1</scp> expression predicts efficacy in the phase <scp>II SPiReL</scp> trial with <scp>MVP‐S</scp>, pembrolizumab, and low‐dose <scp>CPA</scp> in R/R <scp>DLBCL</scp>","year":2023,"lang":"en","type":"article","venue":"European Journal Of Haematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network; London Health Sciences Centre; Queen Elizabeth II Health Sciences Centre; Health Sciences Centre; Sunnybrook Hospital; Baker Hughes (Canada); McGill University Health Centre; Sunnybrook Health Science Centre","funders":"Merck","keywords":"Medicine; Pembrolizumab; Internal medicine; Population; Oncology; Discontinuation; Gastroenterology; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002023996,0.000523757,0.0005344857,0.0002408329,0.000214498,0.0009525102,0.0003348993,0.0004377477,0.002016984],"category_scores_gemma":[0.001281327,0.0002184023,0.0005555493,0.0001784473,0.0003735246,0.0004349668,0.0002929296,0.001120087,0.00036687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005112808,"about_ca_system_score_gemma":0.0006021524,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003371083,"about_ca_topic_score_gemma":0.0007105017,"domain_scores_codex":[0.9995837,0.0002388737,0.0000218339,0.00005685621,0.00004239427,0.0000563408],"domain_scores_gemma":[0.9990581,0.0002868214,0.0002458122,0.00004816976,0.00004760594,0.0003134919],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3460158,0.006766431,0.5410016,0.0004807673,0.001975321,0.0002674735,0.0001955947,0.005552483,0.02311339,0.0002013957,0.005250867,0.06917892],"study_design_scores_gemma":[0.05447184,0.09079499,0.8186034,0.00008999468,0.002003744,0.001132283,0.0001445406,0.01871072,0.009933057,0.0003473125,0.003710125,0.00005807701],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987079,0.0003530894,0.00007670696,0.0001197437,0.000008546372,0.00006669114,0.0002673272,0.00001321353,0.000386728],"genre_scores_gemma":[0.9985383,0.00008355455,0.0001599041,0.00007187551,0.00002385555,0.00005918885,0.000845229,0.000003599102,0.0002146621],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002023996,"threshold_uncertainty_score":0.01070404,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03453579540337291,"score_gpt":0.3144990109351307,"score_spread":0.2799632155317577,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}